Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Lohr

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Plants|July 15, 2020
Identification of BBX proteins as rate-limiting cofactors of HY5Katharina Bursch, Gabriela Toledo-Ortiz, Marie Pireyre, et al.
Journal of Toxicology and Environmental Health. Part A|June 13, 2012
Optimal strategies for sequential validation of significant features from high-dimensional genomic dataMiriam Lohr, Claudia Köllmann, Evgenia Freis, et al.
Archives of Toxicology|November 27, 2015
Identification of sample annotation errors in gene expression datasetsMiriam Lohr, Birte Hellwig, Karolina Edlund, et al.
Current Biology : CB|March 16, 2010
Arabidopsis female gametophyte gene expression map reveals similarities between plant and animal gametesSamuel E Wuest, Kitty Vijverberg, Anja Schmidt, et al.
Breast Cancer (Tokyo, Japan)|September 25, 2012
Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell responsePatricio Godoy, Cristina Cadenas, Birte Hellwig, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Loss of circadian clock gene expression is associated with tumor progression in breast cancerCristina Cadenas, Leonie van de Sandt, Karolina Edlund, et al.
International Journal of Cancer|April 9, 2014
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancerPatrick Micke, Johanna Sofia Margareta Mattsson, Karolina Edlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2014
An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancerSatoshi Noguchi, Akira Saito, Masafumi Horie, et al.
Cancer Letters|February 2, 2013
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancerMiriam Lohr, Karolina Edlund, Johan Botling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validationJohan Botling, Karolina Edlund, Miriam Lohr, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Plants|July 15, 2020
Identification of BBX proteins as rate-limiting cofactors of HY5Katharina Bursch, Gabriela Toledo-Ortiz, Marie Pireyre, et al.
Journal of Toxicology and Environmental Health. Part A|June 13, 2012
Optimal strategies for sequential validation of significant features from high-dimensional genomic dataMiriam Lohr, Claudia Köllmann, Evgenia Freis, et al.
Archives of Toxicology|November 27, 2015
Identification of sample annotation errors in gene expression datasetsMiriam Lohr, Birte Hellwig, Karolina Edlund, et al.
Current Biology : CB|March 16, 2010
Arabidopsis female gametophyte gene expression map reveals similarities between plant and animal gametesSamuel E Wuest, Kitty Vijverberg, Anja Schmidt, et al.
Breast Cancer (Tokyo, Japan)|September 25, 2012
Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell responsePatricio Godoy, Cristina Cadenas, Birte Hellwig, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Loss of circadian clock gene expression is associated with tumor progression in breast cancerCristina Cadenas, Leonie van de Sandt, Karolina Edlund, et al.
International Journal of Cancer|April 9, 2014
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancerPatrick Micke, Johanna Sofia Margareta Mattsson, Karolina Edlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2014
An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancerSatoshi Noguchi, Akira Saito, Masafumi Horie, et al.
Cancer Letters|February 2, 2013
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancerMiriam Lohr, Karolina Edlund, Johan Botling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validationJohan Botling, Karolina Edlund, Miriam Lohr, et al.
Pageof 2